The Precision CAD Trial

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Coronary Artery Disease
Interventions
OTHER

Medical/Behavioral therapy

"* Sedentary lifestyle: Advise increasing exercise to at least 30 minutes of moderate-intensity aerobic activity 5 days a week.~* Overweight/Obese: Advise calorie reduction, dietician consultation.~* Smoking: standard smoking cessation advice and literature and medical therapy as indicated to include Wellbutrin, nicotine patch etc.~* High LDL cholesterol: a) Start high dose statin if patient not on high dose statin.~ b) If on high dose statin, add ezetimibe 10mg daily c) If statin intolerant, start ezetimibe 10mg, colestid or other bile sequestrant combination.~ d) If still not at goal, start PCSK-9 inhibitor e) LDL cut off of \<55mg/dl in diabetes~* Blood Pressure optimization treatment following 2020 International Society of Hypertension Global Hypertension Practice Guidelines.~* Diabetes management: HbA1c goal 6.5%"

OTHER

Standard of Care

Participants will receive standard of care therapy prescribed by their primary care physician and/or cardiologist.

OTHER

Registry

Participants with BRS of 0 will get measurements of BRS at the time-points specified for the randomized subjects and also for adverse events.

Trial Locations (5)

30097

RECRUITING

Emory Johns Creek Hospiatl, Atlanta

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

30322

RECRUITING

Emory University Hospital, Atlanta

30324

RECRUITING

The Emory Clinic, Atlanta

30342

RECRUITING

Emory Saint Joseph's Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER